India's PLI Scheme: How Production Linked Incentives Are Reshaping Global Manufacturing

The Production Linked Incentive scheme, first announced in 2020, is a targeted industrial policy tool designed to address India's chronic underperformance in manufacturing. India's manufacturing sector contributes only 16% of GDP—compared to China's 27% and South Korea's 25%—despite the country's large labour force. The PLI architecture is simple: companies invest in new manufacturing capacity in India, and the government pays them a percentage (typically 4-6%) of incremental sales above a base year threshold, for a period of five to seven years. The scheme covers mobile phones, pharmaceuticals, medical devices, automobiles, advanced chemistry batteries, textile products, food processing, telecom equipment, white goods, specialty steel, solar photovoltaic modules, and drones. The incentive structure is specifically designed to attract globally competitive companies willing to build genuine manufacturing operations rather than assembly plants. Minimum investment thresholds ranging from ₹100 crore to ₹4,000 crore prevent low-commitment participation. Applications are evaluated on projected employment, technology transfer, and export potential.

PLI's most visible success is in mobile phone manufacturing, where Apple's contract manufacturers have committed to building iPhone assembly lines in India at unprecedented scale. Foxconn's $700 million facility in Tamil Nadu is now exporting iPhones to Europe, the US, and Southeast Asia—India's first significant electronics export success. Tata Electronics, which acquired Wistron's India operations, employs 50,000 workers manufacturing iPhones in Karnataka. Pegatron is building a new facility in Tamil Nadu. Total mobile phone exports from India reached $15.6 billion in FY2024, a 50% increase from the previous year. Beyond Apple, Samsung has expanded its Noida factory and now manufactures phones for export to Europe. The broader electronics PLI covers components including printed circuit boards, camera modules, and chargers, with companies like Dixon Technologies and Bharat FIH emerging as significant exporters. The government estimates the electronics PLI alone could generate $500 billion in electronic manufacturing and $120 billion in exports by 2025-26.

India's pharmaceutical PLI has a strategic dimension beyond economics: COVID-19 exposed India's dangerous dependence on Chinese APIs (Active Pharmaceutical Ingredients) for 70% of its bulk drug requirements. The scheme specifically targets API manufacturing, offering higher incentive rates for bulk drugs deemed critical. Companies including Sun Pharma, Cipla, and Dr Reddy's have committed to building new API manufacturing plants in the designated Bulk Drug Parks in Himachal Pradesh and Gujarat. Foreign investment has followed: Germany's BASF signed a memorandum to invest ₹5,000 crore in specialty chemicals, attracted partly by PLI incentives and partly by the China+1 supply chain diversification imperative. French firm Sanofi has committed to manufacturing insulin and vaccines in India. The pharmaceutical PLI is projected to add ₹6,940 crore in incremental investment and ₹10,492 crore in incremental sales by the time the scheme ends in 2027.

PLI's critics point to implementation gaps that threaten to undermine its ambitions. Land acquisition in India remains painfully slow: a Taiwanese semiconductor firm interested in setting up a chip packaging unit reported spending 18 months navigating state-level land clearances before abandoning the project. Labour law rigidity—Indian states vary enormously in their interpretation of hire-and-fire provisions—deters companies that need workforce flexibility to compete with Vietnamese and Thai manufacturers. Infrastructure gaps persist: power reliability in industrial clusters outside major cities remains a challenge, with outages averaging 4-6 hours per day in some PLI-designated zones. Logistics costs in India are approximately 13-14% of GDP compared to 8% in China and 6% in the US, eroding PLI's cost advantages. The government is aware: the PM GatiShakti National Master Plan for multimodal connectivity is designed to reduce logistics costs to 8% by 2030, but execution timelines are uncertain.

PLI is already influencing global corporate supply chain decisions. Apple's diversification from China to India—driven partly by PLI incentives and partly by geopolitical risk management—is the most high-profile example, but dozens of companies across electronics, chemicals, and textiles are building India redundancy into their supply chains. The 'China+1' strategy has found its most advanced India expression through PLI. Vietnam captured the first wave of China+1 manufacturing, particularly in textiles and electronics assembly. India is now competing for the second wave, targeting higher-value segments: semiconductor packaging, precision engineering, and biopharmaceuticals. The government's target is to raise manufacturing from 16% of GDP to 25% by 2030, adding 100 million manufacturing jobs. Whether PLI can deliver that scale remains uncertain, but early metrics—350,000 direct jobs, $15.6 billion in electronics exports, ₹4,400 crore in payouts—suggest the scheme is moving in the right direction. The critical test will come in 2025-26 when the first major PLI sectors complete their incentive periods and the sustainability of investments without government support becomes apparent.